Challenges and Opportunities for Respiratory Syncytial Virus Vaccines by Anderson, Larry J.; Graham, Barney S.;

Series: Current Topics in Microbiology and Immunology; 372;

GET 20% OFF
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.

Publisher's listprice EUR 160.49
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

66 563 Ft (63 393 Ft + 5% VAT)
Discount 20% (cc. 13 313 Ft off)
Discounted price 53 250 Ft (50 714 Ft + 5% VAT)

66 563 Ft

Availability

printed on demand

Product details:

Edition number 2014
Publisher Springer Berlin Heidelberg
Date of Publication 7 January 2014
Number of Volumes 1 pieces, Book

ISBN 9783642389184
Binding Hardback
No. of pages409 pages
Size 235x155 mm
Weight 7568 g
Language English
Illustrations XI, 409 p. 38 illus., 22 illus. in color. Illustrations, black & white

Long description:

Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. This book brings together in one source what is currently known about the virus: its clinical and epidemiologic features; the host response and pathogenesis of the disease; vaccines, vaccine platforms, and treatment; and animal and tissue culture models of RSV infection. It is designed to organize the critical information relevant to RSV vaccine development, facilitate the assimilation of data, and speed progress toward producing a safe and effective vaccine.

Respiratory Syncytial Virus: Virology, Reverse Genetics, and Pathogenesis of Disease.- Clinical and Epidemiologic Features of Respiratory Syncytial Virus.- Influence of Respiratory Syncytial Virus Strain Differences on Pathogenesis and Immunity.- Structure and Function of Respiratory Syncytial Virus Surface Glycoproteins.- Respiratory Syncytial Virus and Reactive Airway Disease.- Human Genetics and Respiratory Syncytial Virus Disease: Current Findings and Future Approaches.- Innate Immune Responses to Respiratory Syncytial Virus Infection.- The Adaptive Immune Response to Respiratory Syncytial Virus.- Respiratory Syncytial Virus Mechanisms to Interfere with Type 1 Interferons.- Host Gene Expression and Respiratory Syncytial Virus Infection.- Consequences of Immature and Senescent Immune Responses for Infection with Respiratory Syncytial Virus.- Respiratory Syncytial Virus Disease: Prevention and Treatment.- Live-Attenuated Respiratory Syncytial Virus Vaccines.- Subunit and Virus-Like Particle Vaccine Approaches for Respiratory Syncytial Virus.- Gene-Based Vaccine Approaches for Respiratory Syncytial Virus.- Bovine Model of Respiratory Syncytial Virus Infection.- The Cotton Rat S. hispidus Model of Respiratory Syncytial Virus Infection.- The Mouse Model of Respiratory Syncytial Virus Disease.- Human Airway Epithelial Cell Cultures for Modeling Respiratory Syncytial Virus Infection.- Challenges and Opportunities for Respiratory Syncytial Virus Vaccines.

Recently viewed

20% %discount

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

Anderson, Larry J.; Graham, Barney S.

66 563 HUF

53 250 HUF

Nefarious Crimes, Contested Justice – Illicit Sex and Infanticide in the Republic of Venice, 1557–1789: Illicit Sex and Infanticide in the Republic of Venice, 1557–1789

Ferraro, JM;

21 498 HUF

19 349 HUF

20% %discount